Page 1127 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 1127

1102                                       CHAPTER 10



  VetBooks.ir  signs that have been seen. Death can occur within   of ingested lead, versus 1–2% in adults, based on the
                                                          increased calcium requirement of younger animals.
           a few hours of the onset of clinical signs and is often
                                                          Ingestion of forage containing more than 80  ppm
           accompanied by violent convulsions.
                                                          lead may cause chronic lead poisoning. Chronic lead
           Diagnosis                                      exposure results in slowly developing toxic manifes-
           Diagnosis is based on clinical signs and known   tations, which are primarily neurological (peripheral
           exposure to metaldehyde. Clinicopathological tests,   neuropathy) or haematopoietic (anaemia). Exposure
           including CSF analysis, are non-diagnostic and post-  to high levels of lead may result in overt CNS toxic-
           mortem lesions are non-specific. Metaldehyde test-  ity, as lead enters the brain at a dose-dependent rate
           ing can be carried out on stomach contents or serum.  following absorption. Lead deposition in the CNS
                                                          results in acute cerebellar haemorrhage and oedema
           Management                                     from capillary dysfunction.
           The primary aim of treatment is to control convul-
           sions, because there is no antidote available. Mineral  Clinical presentation
           oil or activated charcoal may be beneficial soon after   In horses, lead poisoning is manifested as a combina-
           ingestion  to  minimise  absorption.  Supportive  care   tion of central and peripheral nerve dysfunction, GI
           in addition to treatment for any dehydration or aci-  upset and interference with haematopoiesis. Clinical
           dosis is also warranted.                       signs commonly seen are laryngeal hemiplegia, dys-
                                                          phagia (with associated secondary aspiration pneu-
           Prognosis                                      monia), ataxia, muscle fasciculations, hyperaesthesia,
           Horses that recover do not seem to suffer from any   weight loss and depression. The mild to moderate
           sequelae.                                      anaemia seen with chronic poisoning is primar-
                                                          ily due to disruption of haemoglobin synthesis. An
           LEAD TOXICOSIS                                 increase in nucleated RBCs out of proportion to the
                                                          anaemia suggests lead poisoning, especially when
           Definition/overview                            accompanied by basophilic stippling.
           Lead toxicosis is a rare cause of neurological disease
           in horses and is associated with inadvertent ingestion  Differential diagnosis
           of lead.                                       EMND; anticholinesterase insecticide toxicity
                                                          (organophosphates and carbamates).
           Aetiology/pathophysiology
           Lead is regarded as a global contaminant. The most  Diagnosis
           likely sources of lead for horses are contamination   Definitive diagnosis of lead poisoning is based on
           from nearby mines and smelting operations, dis-  detection of a blood lead concentration greater than
           carded lead-acid batteries and ashes remaining after   0.35 ppm in an animal with appropriate clinical signs.
           combustion of older buildings. Lead-based paints   Greater than 10 ppm lead in liver and kidney samples
           on buildings were a major source of contamination,   is also compatible with lead poisoning. Supportive
           but these are likely only to be found on buildings   analyses include urinary lead concentrations before,
           built before 1960 in most countries. The majority of   and 6–12 hours after, chelation therapy is initiated.
           ingested lead is finely divided and highly available. It
           is solubilised in the acidic environment of the stom-  Management
           ach and readily absorbed from the proximal small   Treatment is aimed at enhancing urinary excretion
           intestine. Atomic similarities mean that bivalent lead   with  chelation  therapy.  Calcium  disodium  ethyl-
           acts like calcium once absorbed. In mammals, most   enediaminetetraacetic acid (EDTA) will accelerate
           lead from chronic exposure is dynamically bound in   excretion from blood and soft tissues, but does little
           the bone matrix. The toxic dose depends on the age of   to lead that is stored in bone. A 6.6% solution of cal-
           the animal, with younger animals absorbing 10–20%   cium disodium EDTA is prepared in 5% dextrose
   1122   1123   1124   1125   1126   1127   1128   1129   1130   1131   1132